CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Triamcinolone Hexacetonide Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2021-05-04. Latest FDA row update: 2026-09-15.
FDA lists 1 package records, with companies: Medexus. Package NDCs: 59137-570-01.
FDA shortage reason: Not stated in the grouped FDA source rows.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Medexus | 59137-570-01 | Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01) | Available | 2026-09-15 |
Source facts
Grouped generic ingredient: Triamcinolone Hexacetonide Injection · 1 package records
Therapeutic categories: Rheumatology
Dosage forms: Injection
Routes: Not stated
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-07T13:54:04+00:00. Derived grouping is documented in this record's derivations.